Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer. References: Johansson Seechurn CCC, Gazic Smilovic I, Colacot T, Zanotti-Gerosa A, Casar Z. Development of concise two-step catalytic approach towards lasofoxifene precursor nafoxidine. Bioorg Med Chem. 2018 May 15;26(9):2691-2697. doi: 10.1016/j.bmc.2018.04.021. Epub 2018 Apr 10. PubMed PMID: 29678534.

纯度：≥98%

CAS：1845-11-0